CAPR Operating Cash Flow Growth
Capricor Therapeutics Inc · Operating Cash Flow Growth
CAPR Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-96.24%period ending
CAPR TTM Cash from Operations YoY % (-9.97% → -96.24%)
Year-over-year change
High-resolution chart · PNG
CAPR operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -96.2384% | |
| -105.1172% | |
| -74.5467% | |
| -65.9013% | |
| -56.1151% | |
| -45.3281% | |
| -56.2545% | |
| -76.007% | |
| -90.757% | |
| -108.2801% | |
| -620.6108% | |
| -437.6545% | |
| -308.4058% | |
| -241.198% | |
| 129.2495% | |
| 141.2077% | |
| 158.2304% | |
| 186.8535% | |
| -67.1769% | |
| -87.8617% | |
| -119.8057% | |
| -89.1496% | |
| -47.3988% | |
| 9.1992% | |
| 34.1976% | |
| 46.6331% | |
| 50.7915% | |
| 30.9663% | |
| 21.8094% | |
| 7.0954% | |
| 2.589% | |
| 19.1813% | |
| 14.1918% | |
| 20.394% | |
| 9.9404% | |
| -3.7141% | |
| 5.2756% | |
| -25.8735% | |
| -46.0775% | |
| -63.3014% | |
| -92.2332% | |
| -4.1016% | |
| -1,228.491% | |
| -247.6791% | |
| -1,244.6836% | |
| -332.7536% | |
| 115.6016% | |
| -351.3478% | |
| 33.6767% | |
| 409.3181% | |
| -180.9738% | |
| 83.1234% | |
| 74.6972% | |
| 56.7311% | |
| 52.9674% | |
| 14.9067% | |
| 20.3583% | |
| 9.6048% | |
| -7.6658% | |
| 5.6845% | |
| -9.8138% | |
| 12.8403% | |
| 25.4893% | |
| 32.7505% | |
| 50.7858% | |
| 49.2755% | |
| 45.5313% | |
| 37.6041% | |
| 23.3569% | |
| -26.3449% | |
| -98.0421% | |
| -181.4143% | |
| -12,386.8148% | |
| -13,543.572% | |
| -9,563.5016% | |
| -6,262.709% | |
| -541.6589% | |
| -293.2012% | |
| -212.5183% | |
| -204.4281% | |
| 27.8932% | |
| 30.8497% | |
| -14.9299% | |
| -34.0769% | |
| -42.7673% | |
| -11.2602% | |
| 25.6532% | |
| 26.224% | |
| 35.6827% | |
| 21.2692% | |
| -45.3911% | |
| -49.8608% | |
| -119.0908% | |
| -946.0014% | |
| -9.9677% |